Edwards Lifesciences reports 3Q results; shares down 6%

Discussion in 'Pharma/Biotech Companies - Stock Discussions' started by Jim Rogers, Oct 24, 2017 at 6:44 PM.

  1. Jim Rogers

    Jim Rogers new user

    Joined:
    Jul 18, 2017
    Messages:
    18
    Likes Received:
    0
    Edwards reported slightly lower-than-expected 3Q results and saw a dip in sales of its critically important transcatheter heart valves from 2Q17, although they grew about 17% from a year earlier. Edwards shares, which were up 22% this year, fell 6% post 3Q earnings. Check out the 3Q earnings highlights: http://alph.st/bee09e5a
     

  2. anonymous

    anonymous Guest

    stock will do better since Andy Issacson has left. What a fucking loser!